Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
gabriella.dettorre@uniroma1.it
Gabriella D'Ettorre
Professore Ordinario
Struttura:
DIPARTIMENTO DI SANITA' PUBBLICA E MALATTIE INFETTIVE
E-mail:
gabriella.dettorre@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Real word outcomes associated with use of raltegravir in older people living with HIV: results from the 60 months follow-up of the RAL-age cohort
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
2020
Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection. A case report
MEDICINE
2020
Preliminary attempt to predict risk of invasive pulmonary aspergillosis in patients with influenza. Decision trees may help?
ANTIBIOTICS
2020
Retinal involvement and ocular findings in COVID-19 pneumonia patients
SCIENTIFIC REPORTS
2020
Ozone as adjuvant support in the treatment of covid-19: a preliminary report of probiozovid trial
JOURNAL OF MEDICAL VIROLOGY
2020
Preventing influenza and influenza like illness during Covid-19 pandemic. A call for action
EARLY HUMAN DEVELOPMENT
2020
Comparison between hospitalized patients affected or not by COVID-19 (RESILIENCY study)
CLINICAL INFECTIOUS DISEASES
2020
Modulation of phenylalanine and tyrosine metabolism in HIV-1 infected patients with neurocognitive impairment: results from a clinical trial
METABOLITES
2020
Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization
LE INFEZIONI IN MEDICINA
2020
Efficacy of daptomycin-containing regimen for treatment of staphylococcal or enterococcal vertebral osteomyelitis: A prospective clinical experience
ANTIBIOTICS
2020
Unexpected increase of myocardial extracellular volume fraction in low cardiovascular risk HIV patients
TRANSLATIONAL MEDICINE COMMUNICATIONS
2020
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II)
CARDIOVASCULAR DIABETOLOGY
2020
Usefulness of bronchoalveolar lavage in suspect COVID-19 repeatedly negative swab test and interstitial lung disease
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE
2020
qSOFA as a new community-acquired pneumonia severity score in the emergency setting
EMERGENCY MEDICINE JOURNAL
2020
The Role of Targeted HIV Screening in the Emergency Department: A Scoping Review
CURRENT HIV RESEARCH
2020
Is teicoplanin a complementary treatment option for COVID-19? The question remains
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
2020
Ozone as adjuvant support in the treatment of COVID-19: A preliminary report of probiozovid trial
JOURNAL OF MEDICAL VIROLOGY
2020
Effect of low or high doses of low-molecular-weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID-19
BRITISH JOURNAL OF HAEMATOLOGY
2020
Nox2 activation in Covid-19
REDOX BIOLOGY
2020
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19
FRONTIERS IN MEDICINE
2020
« prima
< precedente
1
2
3
4
5
6
7
8
9
10
11
12
seguente ›
ultima »
Progetti di Ricerca
Oral bacteriotherapy decontamination for the prevention of Ventilator Associated Pneumonia (VAP) in Intensive Care Unit patients.
Studio della patologia cardiovascolare nel paziente HIV positivo: implicazioni cliniche delle modificazioni del microbiota e dei marcatori sierologici di immunoattivazione
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma